triheptanoin 1000 MG/ML Oral Solution [Dojolvi]
- RxCUI
- 2383561
- RxNorm name
- triheptanoin 1000 MG/ML Oral Solution [Dojolvi]
- Display name
- triheptanoin 1000 MG/ML Oral Solution [Dojolvi]
- Full name
- triheptanoin 1000 MG/ML Oral Solution [Dojolvi]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:57
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DOJOLVI | TRIHEPTANOIN | Ultragenyx Pharmaceutical Inc. | 4cfeb8bd-143e-4dd7-bc34-b0bcda02460d | 2025-06-10 | Warnings, Adverse reactions | 2383561 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 4cfeb8bd-143e-4dd7-bc34-b0bcda02460d | DOJOLVI 8.3 kcal/mL (100 % ) Oral Solution [PSN] · triheptanoin 1000 MG/ML Oral Solution [Dojolvi] [SBD] · Dojolvi 100 % Oral Solution [SY] · Dojolvi 1000 MG/ML Oral Solution [SY] | 4 | 17 | These highlights do not include all the information needed to use DOJOLVI safely and effectively. See full prescribing information for DOJOLVI. DOJOLVI ® (triheptanoin) oral liquid Initial U.S. Approval: 2020 | 20250610 |